Vinter, N. et al. Temporal trends in lifetime risks of atrial fibrillation and its complications between 2000 and 2022: Danish, nationwide, population based cohort study. BMJ 385, e077209 (2024).

Article  PubMed  PubMed Central  Google Scholar 

McDonagh, T. A. et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur. Heart J. 42, 3599–3726 (2021).

Article  CAS  PubMed  Google Scholar 

Hindricks, G. et al. 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur. Heart J. 42, 373–498 (2021).

Article  PubMed  Google Scholar 

Staerk, L. et al. Lifetime risk of atrial fibrillation according to optimal, borderline, or elevated levels of risk factors: cohort study based on longitudinal data from the Framingham Heart Study. BMJ 361, k1453 (2018).

Article  PubMed  PubMed Central  Google Scholar 

Magnussen, C. et al. Sex differences and similarities in atrial fibrillation epidemiology, risk factors, and mortality in community cohorts: results from the BiomarCaRE consortium (biomarker for cardiovascular risk assessment in Europe). Circulation 136, 1588–1597 (2017).

Article  PubMed  PubMed Central  Google Scholar 

Van Gelder, I. C. et al. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur. Heart J. 45, 3314–3414 (2024).

Article  PubMed  Google Scholar 

Mou, L. et al. Lifetime risk of atrial fibrillation by race and socioeconomic status: ARIC study (atherosclerosis risk in communities). Circ. Arrhythm. Electrophysiol. 11, e006350 (2018).

Article  PubMed  PubMed Central  Google Scholar 

Yang, C. et al. Global, regional, and national burdens of heart failure in adolescents and young adults aged 10-24 years from 1990 to 2021: an analysis of data from the global burden of disease study 2021. EClinicalMedicine 79, 102998 (2025).

Article  PubMed  Google Scholar 

Brembilla-Perrot, B. et al. Predictors and prognostic significance of tachycardiomyopathy: insights from a cohort of 1269 patients undergoing atrial flutter ablation. Eur. J. Heart Fail. 18, 394–401 (2016).

Article  PubMed  Google Scholar 

Huizar, J. F. et al. Outcomes of premature ventricular contraction-cardiomyopathy in the veteran population: a secondary analysis of the CHF-STAT study. JACC Clin. Electrophysiol. 7, 380–390 (2021).

Article  PubMed  Google Scholar 

Pott, C. et al. A patient series of dual atrioventricular nodal nonreentrant tachycardia (DAVNNT) - an often overlooked diagnosis? Int. J. Cardiol. 172, e9–e11 (2014).

Article  PubMed  Google Scholar 

Medi, C. et al. Tachycardia-mediated cardiomyopathy secondary to focal atrial tachycardia: long-term outcome after catheter ablation. J. Am. Coll. Cardiol. 53, 1791–1797 (2009).

Article  PubMed  Google Scholar 

Schotten, U., Verheule, S., Kirchhof, P. & Goette, A. Pathophysiological mechanisms of atrial fibrillation: a translational appraisal. Physiol. Rev. 91, 265–325 (2011).

Article  PubMed  Google Scholar 

Spinale, F. G. et al. Chronic supraventricular tachycardia causes ventricular dysfunction and subendocardial injury in swine. Am. J. Physiol. 259, H218–H229 (1990).

CAS  PubMed  Google Scholar 

Armstrong, P. W., Stopps, T. P., Ford, S. E. & de Bold, A. J. Rapid ventricular pacing in the dog: pathophysiologic studies of heart failure. Circulation 74, 1075–1084 (1986).

Article  CAS  PubMed  Google Scholar 

Paelinck, B., Vermeersch, P., Stockman, D., Convens, C. & Vaerenberg, M. Usefulness of low-dose dobutamine stress echocardiography in predicting recovery of poor left ventricular function in atrial fibrillation dilated cardiomyopathy. Am. J. Cardiol. 83, 1668–1671 (1999).

Article  CAS  PubMed  Google Scholar 

van den Berg, M. P., van Veldhuisen, D. J., Crijns, H. J. & Lie, K. I. Reversion of tachycardiomyopathy after beta-blocker. Lancet 341, 1667 (1993).

Article  PubMed  Google Scholar 

Kotecha, D. et al. Efficacy of beta blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis. Lancet 384, 2235–2243 (2014).

Article  CAS  PubMed  Google Scholar 

Wijffels, M. C., Kirchhof, C. J., Dorland, R. & Allessie, M. A. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 92, 1954–1968 (1995).

Article  CAS  PubMed  Google Scholar 

Goette, A. et al. Atrial cardiomyopathy revisited-evolution of a concept: a clinical consensus statement of the European Heart Rhythm Association (EHRA) of the ESC, the Heart Rhythm Society (HRS), the Asian Pacific Heart Rhythm Society (APHRS), and the Latin American Heart Rhythm Society (LAHRS). Europace 26, euae204 (2024).

Article  PubMed  PubMed Central  Google Scholar 

Li, D. et al. Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure. Circulation 104, 2608–2614 (2001).

Article  CAS  PubMed  Google Scholar 

Guichard, J. B. et al. Role of atrial arrhythmia and ventricular response in atrial fibrillation induced atrial remodelling. Cardiovasc. Res. 117, 462–471 (2021).

Article  CAS  PubMed  Google Scholar 

Seibertz, F. et al. Atrial fibrillation-associated electrical remodelling in human induced pluripotent stem cell-derived atrial cardiomyocytes: a novel pathway for antiarrhythmic therapy development. Cardiovasc. Res. 119, 2623–2637 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lenski, M. et al. Arrhythmia causes lipid accumulation and reduced glucose uptake. Basic Res. Cardiol. 110, 40 (2015).

Article  PubMed  Google Scholar 

de Haan, S. et al. AVE0118, blocker of the transient outward current (I(to)) and ultrarapid delayed rectifier current (I(Kur)), fully restores atrial contractility after cardioversion of atrial fibrillation in the goat. Circulation 114, 1234–1242 (2006).

Article  PubMed  Google Scholar 

Reilly, S. N. et al. Atrial sources of reactive oxygen species vary with the duration and substrate of atrial fibrillation: implications for the antiarrhythmic effect of statins. Circulation 124, 1107–1117 (2011).

Article  CAS  PubMed  Google Scholar 

Pabel, S. et al. Effects of atrial fibrillation on the human ventricle. Circ. Res. 130, 994–1010 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Paulus, M. G. et al. Tachycardiomyopathy entails a dysfunctional pattern of interrelated mitochondrial functions. Basic Res. Cardiol. 117, 45 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guichard, J. B. et al. Comparison of atrial remodeling caused by sustained atrial flutter versus atrial fibrillation. J. Am. Coll. Cardiol. 76, 374–388 (2020).

Article  CAS  PubMed  Google Scholar 

Wijesurendra, R. S. et al. Lone atrial fibrillation is associated with impaired left ventricular energetics that persists despite successful catheter ablation. Circulation 134, 1068–1081 (2016).

Article  PubMed  PubMed Central  Google Scholar 

Billing, A. M. et al. Metabolic communication by SGLT2 inhibition. Circulation 149, 860–884 (2024).

Article  CAS  PubMed  Google Scholar 

Roselli, C. et al. Multi-ethnic genome-wide association study for atrial fibrillation. Nat. Genet. 50, 1225–1233 (2018).

Article  CAS